ISMP Guidelines for Optimizing Safe Subcutaneous Insulin Use in Adults. | AHRQ Patient Safety Network

ISMP Guidelines for Optimizing Safe Subcutaneous Insulin Use in Adults. | AHRQ Patient Safety Network

• Organizational Policy/Guidelines
 
• Published May 2017

ISMP Guidelines for Optimizing Safe Subcutaneous Insulin Use in Adults.

Horsham, PA: Institute for Safe Medication Practices; May 2017.

Insulin is a widely used medication that can contribute to serious patient harm if used incorrectly. This report provides information about problems associated with insulin use in adults and offers consensus-developed strategies to encourage subcutaneous insulin practices that reduce errors at the prescribing, pharmacy management, administration, and transition phases.

Free full text (PDF)

Related Resources

CASES & COMMENTARIES

High-Risk Medications, High-Risk Transfers

Nancy Staggers, PhD, RN

JOURNAL ARTICLE › COMMENTARY

Making surgical wards safer for patients with diabetes: reducing hypoglycaemia and insulin errors.

Singh A, Adams A, Dudley B, Davison E, Jones L, Wales L. BMJ Open Qual 2018;7:e000312.

JOURNAL ARTICLE › COMMENTARY

Insulin dosing error in a patient with severe hyperkalemia.

Hewitt DB, Barnard C, Bilimoria KY. JAMA. 2017;318:2485-2486.

JOURNAL ARTICLE › STUDY

Randomized controlled evaluation of an insulin pen storage policy.

Gibbs HG, McLernon T, Call R, et al. Am J Health Syst Pharm. 2017;74:2054-2059.

PRESS RELEASE/ANNOUNCEMENT

Severe hyperglycemia in patients incorrectly using insulin pens at home.

National Alert Network. Horsham, PA: Institute for Safe Medication Practices; Bethesda, MD: American Society of Health-System Pharmacists. October 12, 2017.

View More